Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,897 | 36,078 | 36,194 | 40,320 | 49,854 |
| Other current assets | 0 | 0 | 3,117 | 3,117 | 0 |
| TOTAL | $52,226 | $36,674 | $40,159 | $44,841 | $50,039 |
| Non-Current Assets | |||||
| PPE Net | 14 | 15 | 16 | N/A | N/A |
| Intangibles | 14,869 | 14,869 | 14,869 | 14,869 | 14,869 |
| Other Non-Current Assets | 30 | 36 | 43 | 49 | 51 |
| TOTAL | $14,913 | $14,921 | $14,928 | $14,918 | $14,921 |
| Total Assets | $67,139 | $51,595 | $55,087 | $59,759 | $64,959 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 298 | 961 | 970 | 533 | 1,520 |
| Accrued Expenses | 1,610 | 1,541 | 408 | 1,664 | 1,889 |
| TOTAL | $1,908 | $2,502 | $1,378 | $2,197 | $3,409 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 77,742 | 75,711 | 73,734 | 71,808 | 69,933 |
| TOTAL | $77,742 | $75,711 | $73,734 | $71,808 | $69,933 |
| Total Liabilities | $79,650 | $78,213 | $75,112 | $74,005 | $73,342 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,993 | 5,568 | 5,340 | 5,340 | 5,340 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -379,973 | -373,781 | -366,810 | -360,084 | -353,184 |
| TOTAL | $-12,511 | $-26,618 | $-20,024 | $-14,246 | $-8,382 |
| Total Liabilities And Equity | $67,139 | $51,595 | $55,087 | $59,759 | $64,959 |